Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Simon

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Frontiers in Pediatrics|May 8, 2026
Status Quo analysis of an exercise therapy care model in pediatric oncology during acute therapy: perspectives from patients, parents, siblings, and staffLena Böhlke, Thorsten Simon, Barbara Hero, et al.
British Journal of Cancer|July 12, 2018
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidationFrank Berthold, Angela Ernst, Barbara Hero, et al.
Nuklearmedizin. Nuclear Medicine|April 14, 2022
Matthias Schmidt, Boris Decarolis, Christiane Franzius, et al.
Cancer Medicine|October 22, 2019
A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosisKiana Kreitz, Angela Ernst, René Schmidt, et al.
Developmental Medicine and Child Neurology|February 15, 2012
Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastomaThorsten Simon, Catherina Annika Niemann, Barbara Hero, et al.
Journal of Geophysical Research. Atmospheres : JGR|March 5, 2024
Upward Lightning at the Gaisberg Tower: The Larger-Scale Meteorological Influence on the Triggering Mode and Flash TypeIsabell Stucke, Deborah Morgenstern, Gerhard Diendorfer, et al.
Journal of Cancer Research and Clinical Oncology|May 5, 2007
Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trialThorsten Simon, Alfred Längler, Urs Harnischmacher, et al.
Journal of Geophysical Research. Atmospheres : JGR|March 5, 2024
Upward Lightning at Wind Turbines: Risk Assessment From Larger-Scale MeteorologyIsabell Stucke, Deborah Morgenstern, Gerhard Diendorfer, et al.
Pediatric Hematology and Oncology|June 29, 2010
Residual lymph node metastasis in stage 4 neuroblastoma--advantage of radio-guided surgery?Robin Wachowiak, Holger Till, Roman Metzger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison studyBoris Decarolis, Christina Schneider, Barbara Hero, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Frontiers in Pediatrics|May 8, 2026
Status Quo analysis of an exercise therapy care model in pediatric oncology during acute therapy: perspectives from patients, parents, siblings, and staffLena Böhlke, Thorsten Simon, Barbara Hero, et al.
British Journal of Cancer|July 12, 2018
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidationFrank Berthold, Angela Ernst, Barbara Hero, et al.
Nuklearmedizin. Nuclear Medicine|April 14, 2022
Matthias Schmidt, Boris Decarolis, Christiane Franzius, et al.
Cancer Medicine|October 22, 2019
A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosisKiana Kreitz, Angela Ernst, René Schmidt, et al.
Developmental Medicine and Child Neurology|February 15, 2012
Short- and long-term outcome of patients with symptoms of spinal cord compression by neuroblastomaThorsten Simon, Catherina Annika Niemann, Barbara Hero, et al.
Journal of Geophysical Research. Atmospheres : JGR|March 5, 2024
Upward Lightning at the Gaisberg Tower: The Larger-Scale Meteorological Influence on the Triggering Mode and Flash TypeIsabell Stucke, Deborah Morgenstern, Gerhard Diendorfer, et al.
Journal of Cancer Research and Clinical Oncology|May 5, 2007
Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trialThorsten Simon, Alfred Längler, Urs Harnischmacher, et al.
Journal of Geophysical Research. Atmospheres : JGR|March 5, 2024
Upward Lightning at Wind Turbines: Risk Assessment From Larger-Scale MeteorologyIsabell Stucke, Deborah Morgenstern, Gerhard Diendorfer, et al.
Pediatric Hematology and Oncology|June 29, 2010
Residual lymph node metastasis in stage 4 neuroblastoma--advantage of radio-guided surgery?Robin Wachowiak, Holger Till, Roman Metzger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison studyBoris Decarolis, Christina Schneider, Barbara Hero, et al.
Pageof 13